Acceptability of buprenorphine as a treatment for opioid use disorders: Experiences of health providers in Indiana rural counties

Simple item page
dc.contributor.authorMwangi, Josephine
dc.contributor.authorBarnes, Priscilla
dc.contributor.authorAgley, Jon
dc.contributor.authorSmall, Meredith
dc.contributor.authorAdams, Melanie
dc.date.accessioned2021-01-11T20:09:49Z
dc.date.available2021-01-11T20:09:49Z
dc.date.issued2020-10-19
dc.descriptionPoster presentation at the 2020 American Public Health Association Virtual Annual Meeting and EXPO.
dc.description.abstractThis ongoing qualitative study uses medical (72.4%) and non-medical (27.6%) providers’ narratives to explore barriers and facilitators of buprenorphine – an approved Medication Assisted Treatment (MAT). Please note that the poster presentation represents preliminary findings which may change after data collection is completed.
dc.identifier.urihttps://hdl.handle.net/2022/26071
dc.language.isoen
dc.rightsThis work may be protected by copyright unless otherwise stated.
dc.subjectRural
dc.subjectIndiana
dc.subjectHealth
dc.subjectSubstance use
dc.titleAcceptability of buprenorphine as a treatment for opioid use disorders: Experiences of health providers in Indiana rural counties
dc.typePresentation

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
APHA-Presentation-Mwangi etal. PDFx.pdf
Size:
91.07 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Health
Can’t use the file because of accessibility barriers? Contact us